NTAP vs TGTX · P/E 28, rev $6.24B vs P/E 18, rev $240.3M
NetApp Inc (NTAP) versus TG Therapeutics Inc (TGTX) — a side-by-side from cached financials, not a winner call.
NetApp Inc (NTAP) is a software - infrastructure company listed on US.
TG Therapeutics Inc (TGTX) is a biotechnology company listed on NASDAQ.
Latest reported NTAP revenue for 2026-04-24 was $6.24B. Net income was $1.28B. Revenue was down 5.1% from 2025-04-25 to 2026-04-24. NTAP currently screens at market cap $35.43B and trailing P/E 28.2.
Latest reported TGTX revenue for 2026-06-30 was $240.3M. Net income was $7.8M. Revenue was up 17.3% from 2026-03-31 to 2026-06-30. TGTX currently screens at market cap $7.88B and trailing P/E 18.0.
NTAP currently screens at market cap $35.43B and trailing P/E 28.2. TGTX currently screens at market cap $7.88B and trailing P/E 18.0.
Not investment advice. Open the NTAP and TGTX stock pages for the full models.
Not investment advice.